Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).
暂无分享，去创建一个
E. Jaffee | W. Burns | E. Fertig | E. Sugar | D. Laheru | M. Weiss | R. Burkhart | R. Anders | M. Yarchoan | J. Durham | A. Popovic | N. Gross | J. Leatherman | B. Philosophe | Qingfeng Zhu | Shu Zhang | W. J. Ho | Soren Charmsaz | Bradley Wilt